Last reviewed · How we verify
Capecitabine and Sorafenib
Capecitabine and Sorafenib is a Small molecule drug developed by SCRI Development Innovations, LLC. It is currently in Phase 1 development. Also known as: Xeloda, Nexavar.
At a glance
| Generic name | Capecitabine and Sorafenib |
|---|---|
| Also known as | Xeloda, Nexavar |
| Sponsor | SCRI Development Innovations, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- SNF Platform Study of HR+/ HER2-advanced Breast Cancer (PHASE2)
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial (PHASE1)
- Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer (PHASE2)
- Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma (PHASE2)
- Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer (PHASE1, PHASE2)
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine (PHASE1, PHASE2)
- Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer (PHASE2)
- Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Capecitabine and Sorafenib CI brief — competitive landscape report
- Capecitabine and Sorafenib updates RSS · CI watch RSS
- SCRI Development Innovations, LLC portfolio CI
Frequently asked questions about Capecitabine and Sorafenib
What is Capecitabine and Sorafenib?
Capecitabine and Sorafenib is a Small molecule drug developed by SCRI Development Innovations, LLC.
Who makes Capecitabine and Sorafenib?
Capecitabine and Sorafenib is developed by SCRI Development Innovations, LLC (see full SCRI Development Innovations, LLC pipeline at /company/scri-development-innovations-llc).
Is Capecitabine and Sorafenib also known as anything else?
Capecitabine and Sorafenib is also known as Xeloda, Nexavar.
What development phase is Capecitabine and Sorafenib in?
Capecitabine and Sorafenib is in Phase 1.
Related
- Manufacturer: SCRI Development Innovations, LLC — full pipeline
- Also known as: Xeloda, Nexavar
- Compare: Capecitabine and Sorafenib vs similar drugs
- Pricing: Capecitabine and Sorafenib cost, discount & access